KDR and neoplasm: However, normalizing doses of anti-VEGFR2 decreased the frequencies of tumor-infiltrating neutrophils and macrophages, suggesting that vessel normalization may inhibit tumor growth by alleviating myeloid-mediated immune suppression (Supplementary Fig. 6F), but not by directly enhancing T cell recruitment.